Has Brett Levine, MD received payments from drug or device companies?

Yes. Drug and device makers reported $45,824 in general payments to Brett Levine, MD across 162 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brett Levine, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brett Levine, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brett Levine, MD

Otolaryngology · Torrance, CANPI 1063413110

Payments from drug & device makers

What this record shows

This record is dominated by education: $39,535 of the $45,824 with a category attached, or 86.3%. Olympus America Inc. accounts for 86.3% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2020 at $40,303 and has fallen 97.2% since, to $1,127 in 2025. Among otolaryngology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$45,824in general payments, 2019–2025

Across 162 payments — averaging $282.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Olympus America Inc.$40K
Stryker$2K
GSK$850
Regeneron Healthcare Solutions, Inc.$822
Sanofi$553
Medical Device Business Services, Inc.$487
plus $2K from 26 others

What the payments were for

Consulting fees$500%
Travel & lodging$1,0542%
Food & beverage$5,18411%
Education$39,53586%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Olympus America Inc.	2	$39,547
Stryker	21	$1,804
GSK	30	$850
Regeneron Healthcare Solutions, Inc.	22	$822
Sanofi	19	$553
Medical Device Business Services, Inc.	2	$487
Acclarent, Inc	9	$334
Optinose US, Inc.	14	$241
Zimmer Biomet	4	$193
Aerin Medical Inc.	4	$138
Bard Access Systems, Inc.	1	$94
Merz Pharmaceuticals, LLC	2	$72
Smith+Nephew	4	$70
Baxter Healthcare	2	$66
Hikma Pharmaceuticals USA	3	$55
Next Science LLC	2	$53
Amgen	2	$48
Merck	2	$45
Intersect ENT, Inc.	2	$41
Cook Medical LLC	2	$40
Agiliti Surgical, Inc.	2	$34
Medline Industries LP	1	$33
Inspire Medical Systems, Inc.	1	$33
ARS Pharmaceuticals Operations, Inc.	1	$29
Lilly USA, LLC	1	$23
Acera Surgical, Inc.	1	$21
Xoran Technologies LLC	1	$20
Medtronic	1	$18
Arbor Pharmaceuticals, Inc.	1	$16
KARL Storz Endoscopy-america	1	$15
Tactile Systems Technology Inc	1	$14
Johnson & Johnson	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Surgical Light Sources$39,535
Surgical Camera Heads$39,535
Surgical Processors$39,535
ENTELLUS - XPRESS ENT DILATION SYSTEM$532
XPRESS ENT DILATION SYSTEM$299
XPRESS LOPROFILE$217
CLARIFIX CRYOTHERAPY DEVICE$165
ACCLARENT NAVWIRE Sinus Navigation Guidewire$119
Persona$112
SCOPIS ENT$110
LATERA$110
CLARIFIX$108

How this compares

$45,824 in reported general payments places this provider in the 95th percentile of 1,021 otolaryngology providers in California.

See all otolaryngology providers in California →

Medicare billing

Part B allowed, 2024

$142,861

Medicare patients

398

Services billed

1,059

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluticasone Propionate	371	$9,661
Azelastine Hcl	60	$1,936
Ipratropium Bromide	22	$999
Doxycycline Hyclate	97	$854
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort	16	$781
Cefdinir	32	$713
CefuroximeCefuroxime Axetil	55	$627
Fluocinolone Acetonide Oil	13	$470
Clarithromycin	22	$401
Cephalexin	21	$263
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	20	$262
Famotidine	14	$238
Methylprednisolone	38	$209
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	38	$197
Ciprofloxacin Hcl	21	$171

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Torrance

Steven DavisTorrance$50K
Brian WeeksSan Diego$924K
Randall OwRoseville$613K
Amir MoradiVista$389K
Keith BlackwellLos Angeles$349K
Kalpna DurairajSun Valley$348K
Todd MillerNewport Beach$259K
Jeffrey SuhLos Angeles$223K
Dennis TangLos Angeles$209K
Jeffrey FeinfieldThousand Oaks$160K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →